tuberculosis

(redirected from MDR-TB)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for tuberculosis

TB

Synonyms for tuberculosis

an infectious disease producing lesions especially of the lungs

Synonyms for tuberculosis

infection transmitted by inhalation or ingestion of tubercle bacilli and manifested in fever and small lesions (usually in the lungs but in various other parts of the body in acute stages)

References in periodicals archive ?
Riordan et al, recommended line probe assay (LPA) for the detection of MDR-TB in 20088.
In our efforts to deal with MDR-TB, we forget that the biggest action on MDR-TB is prevention.
This is the first known case of clinical resolution of symptoms in a joint with proven bacterial septic arthritis and concomitant MDR-TB infection without TB treatment.
In 2009, Global Fund intended to conduct a program in Zhejiang Province to estimate MDR-TB burden.
Lower education, greater number of previous TB episodes and co-morbidity were independently associated with mortality among MDR-TB cases.
This was a retrospective, record-based study of MDR-TB patients who were admitted in DR-TB center Miraj since year 1st July 2013 to 30th June 2015.
The novel diagnostic test - called MTBDRsl - is a DNA-based test that identifies genetic mutations in MDR-TB strains, making them resistant to fluoroquinolones and injectable second-line TB drugs.
There has been a marked decline in TB burden in the country since the launching of the Directly Observed Treatment Short-Course strategy in 1996, and this partnership in the fight against MDR-TB will intensify our efforts in our battle against TB, Garin said.
Effective treatment of MDR-TB patients through implementation of RNTCP DOTS Plus (Category IV services).
2%) of new cases and 20% (13-26%) of retreated cases are estimated to have MDR-TB [2].
The new strains that are resistant to antibiotics are much harder to treat, and now nearly 500,000 cases of MDR-TB occur each year.
The UN health agency estimates that 450,000 people fell ill with MDR-TB in 2012 alone, with China, India and Russia worst affected, followed by another 24 other countries.
The disposable Q-TB cartridge, being developed in a threeyear PS2m project, will be used on Q-POC, QuantuMDx's handheld diagnostic device, and provide a technology leap for both developing nations which lack healthcare infrastructure and the overburdened healthcare systems of developed nations which are seeing an re-emergence of MDR-TB, particularly within inner cities.
MDR-TB has been spreading fast and "MSF is seeing vast amounts of drug resistance even in newly diagnosed persons in some of our projects," said Dr Aloudat.